More than 40 years after a then-experimental bone marrow transplant for aplastic anemia, Jessica Brilliant Keener is thriving — and giving back every day to the institutions that gave her a second chance at life. Aplastic anemia occurs when bone marrow needed to supply all the body’s blood cells produces too few of those required … Read more
It’s impossible not to notice the connection between Crista Cardillo and Kim Stegmaier, MD. The way they laugh and swap stories might make you think they grew up down the street from one another. But their friendship began differently than most: as patient and oncologist at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. When Cardillo … Read more
Strength training is a type of exercise in which one uses resistance to force the muscles to contract to build strength. Resistance for strengthening can come from a person’s own body weight or from gym equipment. We spoke to Nancy Campbell, MS, an exercise physiologist at Dana-Farber’s Leonard P. Zakim Center for Integrative Therapies, who … Read more
The first time Bill Cronin Googled his own cancer diagnosis in 2016, his heart sank. He had Sézary syndrome, a rare and aggressive form of cutaneous T-cell lymphoma — and staring back at him were countless articles predicting a negative prognosis. However, after receiving a stem-cell transplant at Dana-Farber/Brigham and Women’s Cancer Center, Cronin is … Read more
A number of research studies suggest that people who consume a lot of milk and other dairy products have a somewhat lower risk of developing colon cancer than those who don’t. But many people avoid or minimize dairy consumption because they are “lactose intolerant,” meaning they have difficulty digesting lactose — a sugar found in … Read more
This post originally appeared on Discoveries, the blog of Boston Children’s Hospital. Eva Quiroz loves horses. The 10 year old takes riding lessons, and this activity puts a smile on her face. Anyone watching her contentedly guiding a horse around the ring would just assume she has always been a healthy child, says her mom … Read more
While screening for pancreatic cancer is not recommended for people at average risk of the disease, screening is recommended for those who carry an inherited genetic mutation associated with pancreatic cancer and have a family history of the disease. (Mutations are abnormal stretches of DNA that alter how cells grow and divide.) People with an … Read more
For many years, Thomas Palayoor and his wife, Sanjeewani, were engaged in cancer research in India. Inspired by the revolutionary advances being made in the biomedical field in the United States, they decided to move to the U.S. in 1978. Working at the medical schools of Ohio State University and Yale University, Palayoor branched off … Read more
In golf, the best shot isn’t always the one that goes the furthest. Sometimes, a golfer should “lay up,” or play conservatively. Exchanging power for precision and avoiding potential hazards can set them up for what’s next. Avid golfer Evan Cornelius, 20, understands this better than most. So when it came time for him to … Read more
Medically reviewed by Brian M. Wolpin, MD, MPH Itching that occurs periodically is not a sign of pancreatic cancer. In fact, most people diagnosed with the disease will not experience this symptom. A potential symptom of pancreatic cancer is progressive itching that intensifies over a few weeks and is accompanied by jaundice (yellowing of the … Read more
Immunotherapy for cancer has made some of its biggest inroads against hematologic malignancies such as leukemia and lymphoma, with treatments such as checkpoint inhibitors and CAR T-cell therapies producing long-lasting remissions in some patients. But there’s broad agreement that the potential of such therapies has only begun to be tapped and that combining immunotherapy drugs … Read more
The approval of the drug tazemetostat to treat epithelioid sarcomas is a victory for patients and a vindication of the idea that success may take different forms in different cancers. It’s also an affirmation of the value of research at Dana-Farber that began in the early 2000s with basic science discoveries and progressed into clinical … Read more
As a federal probation officer, Ryan Fox brings empathy to her role working with prisoners and their families. Knowing there is often more to a case than meets the eye, she partners with lawyers, judges, and others in the court system to give inmates a fresh start and an opportunity to tell their stories. She’s … Read more
For designers of targeted drugs, the biggest bullseye in prostate cancer has been the androgen receptor — a specialized net on prostate cells that snares androgen molecules to spur the cells’ growth. Drugs that block, or inhibit, the receptor can halt the cancer, but not all patients benefit from them, and nearly all those who … Read more
While the vast majority of people diagnosed with cancer do not develop a different malignancy later in life, it’s important for survivors to be aware of factors that can put them at risk. People who have had cancer may in some cases have a higher than average risk of developing a new cancer — that … Read more
Medically reviewed by Michael Cheng, MD A report from the International Agency for Research on Cancer (IARC), found that in 2010, air pollution was responsible for 223,000 deaths from lung cancer worldwide. The findings were so striking that they prompted the agency, a part of the World Health Organization (WHO), to classify outdoor air pollution … Read more
When Kirsten Erlandsen was diagnosed with triple negative breast cancer in 2008, she approached her treatment like it was one of her road races. The mother of two knew that completing each treatment session brought her one stop closer to the “finish line” and her goal of becoming cancer-free. However, after a year of running … Read more
Perhaps the biggest challenge in precision cancer therapy is tumors’ nasty habit of rebounding after an initial attack with targeted drugs has shrunk them almost out of existence. Instead of vanishing completely, curing the patient, the tumors leave behind a small cadre of cells that slumber in a dormant state, only to return in a … Read more
Watching her deftly maneuver a playground with a huge smile on her face makes it hard to imagine that Anabella Trillo, 3, once faced challenges far greater than a jungle gym. In fact, she has already endured surgery, radiation, chemotherapy, and a stem cell transplant for one of the most aggressive pediatric cancers: a malignant … Read more
This post originally appeared on Discoveries, the blog of Boston Children’s Hospital. A drug used for rheumatoid arthritis has moved a step closer to U.S. Food and Drug Administration (FDA) approval for a desperately needed new use. The drug, abatacept, has gained FDA breakthrough therapy designation for preventing acute, severe graft-versus-host disease (GVHD) in patients receiving bone … Read more